Trial Profile
Orlistat effect in correlation with weight loss and hepatic dysfunction in obese patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Adverse reactions; Therapeutic Use
- 21 Aug 2015 New trial record